Ilepatril TFA
Ilepatril TFA is a dual inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP), exhibiting physiological effects such as enhanced natriuresis and vasodilation. In animal studies and early clinical trials, Ilepatril TFA has demonstrated the ability to improve insulin sensitivity and metabolic abnormalities, suggesting its potential value in the treatment of cardiovascular and metabolic diseases.
Product Specifications
Purity
99.74% (May vary between batches)
Smiles
C ([C@@H]1CCC[C@@H]2C3C=CC=CC=3C[C@@H] (C (N12) =O) NC (=O) [C@H] (C (C) C) SC (=O) C) (=O) O.C (=O) (O) C (F) (F) F
Molecular Formula
C24H29F3N2O7S
Molecular Weight
546.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15367154 1 Vial
Lentiviral human RALGAPB sgRNA gene knockout kit - Lentiviral human RALGAPB sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 302935 Pack of 1 Pictogram(s)
W/W022/EN230-PEUL-100X50/1-B AC Signs
Sign In for Pricing
View Details